Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CVS Health Corporation CVS

Set alert

Price alert · CVS

All alert types
89.16 USD +0.65 +0.74%

As of Nov 3, 10:12 AM ET

Bid
89.15 × 1
Ask
89.17 × 2
88.02 Day range 89.50
69.51 52-week range 110.68
YTD
+12.35%
1 year
+13.67%
Open
88.43
Prev close
88.51
Mkt cap
114.02B
Vol
983.14K
Avg vol
8.03M
EPS
3.80
P/E
23.46
Div yield
2.94%
More statistics
Low
88.02
High
89.50
Forward P/E
10.37
Beta
0.58
Short ratio
1.63
Inst. own
90.99%
Dividend
2.66
Ex-div date
Oct 21, 2026
Earnings
Nov 4, 2026
50-d avg
91.23
200-d avg
88.79
1y target
115.48

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 5, 2026Earnings: 2.58; estimate 1.85; surprise 39.46%
  • Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Aug 6, 2026Rating: UBS · Buy → Buy
  • Aug 12, 2026Rating: JP Morgan · Overweight → Overweight
  • Aug 19, 2026Rating: Argus Research · Buy → Buy
  • Sep 3, 2026Rating: UBS · Buy → Buy
  • Oct 12, 2026Rating: Leerink Partners · Outperform → Outperform
  • Oct 22, 2026Dividend: 0.665
Signals (12)
NameDateAgo
SMA: BearishNov 2, 20261 day ago
MACD: Sell SignalOct 30, 20264 days ago
SMA: BearishOct 27, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BullishOct 14, 20262 weeks ago
MACD: Buy SignalOct 6, 20264 weeks ago
RSI: OversoldSep 18, 20261 month ago
MACD: Sell SignalSep 17, 20261 month ago
MACD: Buy SignalAug 31, 20262 months ago
RSI: OversoldAug 11, 20262 months ago
SMA: BearishAug 5, 20263 months ago
SMA: BearishAug 4, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 115.48 +29.5% upside
Target (low)
103.00
Target (mean)
115.48
Target (high)
145.00
Ratings (0m) 27 25 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy18
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 27
  • 1 month ago 27
  • 2 months ago 27

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CVS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.651.52 – 1.871.60+3.2%104.69B+1.8%23
Next quarter1.241.08 – 1.361.09+14.1%106.86B+1.1%23
Current year8.047.94 – 8.156.75+19.1%417.87B+3.9%25
Next year8.548.43 – 9.058.04+6.1%430.08B+2.9%26

Upgrades and downgrades

The latest rating changes

CVS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Leerink PartnersMaintainedOutperformOutperform
Sep 3, 2026UBSMaintainedBuyBuy
Aug 19, 2026Argus ResearchMaintainedBuyBuy
Aug 12, 2026JP MorganMaintainedOverweightOverweight
Aug 6, 2026UBSMaintainedBuyBuy
Aug 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Aug 6, 2026BarclaysMaintainedOverweightOverweight
Jul 24, 2026UBSMaintainedBuyBuy
Jul 14, 2026Truist SecuritiesMaintainedBuyBuy
Jul 13, 2026Wells FargoMaintainedOverweightOverweight
Jul 9, 2026RBC CapitalMaintainedOutperformOutperform
Jul 7, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Jun 23, 2026B of A SecuritiesMaintainedBuyBuy
Jun 8, 2026MizuhoMaintainedOutperformOutperform
Jun 4, 2026Morgan StanleyMaintainedOverweightOverweight
Jun 1, 2026Truist SecuritiesMaintainedBuyBuy
May 26, 2026BarclaysMaintainedOverweightOverweight
May 20, 2026MizuhoMaintainedOutperformOutperform
May 14, 2026Morgan StanleyMaintainedOverweightOverweight
May 13, 2026BernsteinMaintainedOutperformOutperform
May 12, 2026JP MorganMaintainedOverweightOverweight
May 11, 2026TD CowenMaintainedBuyBuy
May 8, 2026Wells FargoMaintainedOverweightOverweight
May 7, 2026UBSMaintainedBuyBuy
May 7, 2026RBC CapitalMaintainedOutperformOutperform
May 7, 2026BarclaysMaintainedOverweightOverweight
May 7, 2026Truist SecuritiesMaintainedBuyBuy
May 7, 2026Evercore ISI GroupMaintainedOutperformOutperform
Apr 15, 2026BairdMaintainedOutperformOutperform
Mar 31, 2026Piper SandlerMaintainedOverweightOverweight